The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBIDS.L Regulatory News (BIDS)

  • There is currently no data for BIDS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share Option Schemes & Grant of Options

25 Jul 2016 08:45

RNS Number : 1077F
Fitbug Holdings PLC
25 July 2016
 

Fitbug Holdings Plc / Epic: FITB.L / Index: AIM / Sector: Leisure

 

25 July 2016

FITBUG HOLDINGS PLC ('FITBUG' OR 'THE COMPANY')

Adoption of Share Option Schemes and Grant of Options

 

Fitbug Holdings Plc, the AIM quoted technology developer and digital wellness pioneer, is pleased to announce that, as set out in the Circular to shareholders on 29 June 2016, following admission of its enlarged issued share capital to trading on AIM this morning, it has adopted two new share option schemes, the Fitbug Holdings plc Enterprise Management Incentive Share Option Scheme 2016 and the Fitbug Holdings plc Unapproved Share Option Scheme 2016, for directors, employees, and certain other persons engaged in the business of the Group (the "New Schemes").

The Company has also granted options over an aggregate of 113,837,413 Ordinary Shares, representing 9.24% of the enlarged issued share capital of the Company pursuant to the New Schemes. The options are all exercisable between the third and tenth anniversary of grant or in the event of a takeover. One third of the options held by each option holder will be exercisable at 0.25p per share, one third at 0.35p per share and the remainder at 0.5p per Ordinary Share.

 

Options granted to the directors and other persons discharging managerial responsibilities are as follows:

 

Name

Options issued at 0.25p exercise price

Options issued at 0.35p exercise price

Options issued at 0.5p exercise price

Total number of options held

Percentage of enlarged issued share capital

Donald Stewart

4,925,468

4,925,468

4,925,468

14,776,404

1.2%

Anna Gudmundson

18,470,505

18,470,505

18,470,505

55,411,514

4.5%

Tyler Tarr

3,694,101

3,694,101

3,694,101

11,082,303

0.9%

Mark Ollila

3,694,101

3,694,101

3,694,101

11,082,303

0.9%

Richard Goodlad

3,694,101

3,694,101

3,694,101

11,082,303

0.9%

Total

34,478,275

34,478,275

34,478,275

103,434,825

8.4%

 

 

 

**ENDS**

 

Anna Gudmundson / Donald Stewart

 

Fitbug Holdings Plc

020 7449 1000

Marc Milmo/ Catherine Leftley

Cantor Fitzgerald Europe, Nomad and Joint Broker

 

020 7894 7000

Claire Louise Noyce / William Lynne / Niall Pearson

 

Hybridan LLP, Joint Broker

020 3764 2341

Elisabeth Cowell / Charlotte Heap

St Brides Partners Ltd, Public Relations

020 7236 1177

 

Notes

About Fitbug®

Fitbug is a leading provider of online health and well-being services which is pioneering an innovative 'Digital Wellness' model to help individuals to improve their lifestyles by making realistic changes to their daily routine. It combines activity tracking devices, which provide an understanding of each user's daily activity achievements, with mobile and web technology, which provides users with personalised weekly activity and nutrition targets, feedback, advice and encouragement to achieve "wellness". This is centred on four key areas: stress, sleep, nutrition and activity.

Its "Kiqplan"TM digital health coaching platform is designed to make wearable technology relevant to new audiences and take the "so what?" out of activity tracking by providing structured action plans to help people achieve their wellness goals.

 

The Company is primarily focussed on the B2B market, mainly mid-to-large cap corporations and insurance brokers / health insurers, where significant growth opportunities have been identified, particularly in the UK and US. An important part of the Company's focus is on building strategic relationships with organisations, which can integrate Fitbug or Kiqplan into their own service/product offerings or resell to their customer base. For more information, visit www.fitbug.com and www.kiqplan.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGUPCMUPQUMA
Date   Source Headline
23rd Apr 20247:00 amRNSCancellation - Bidstack Group PLC
22nd Mar 20241:11 pmRNSAppointment of Administrators & Nomad Resignation
11th Mar 20247:30 amRNSSuspension - Bidstack Group PLC
11th Mar 20247:00 amRNSIntention to Appoint Administrators & Suspension
5th Feb 20247:00 amRNSUpdate on CLN, Financial Update & Strategic Review
22nd Dec 20237:00 amRNSSettlement & new commercial partnership - Azerion
1st Nov 20237:00 amRNSChange of Registered Office
18th Oct 20233:45 pmRNSProposed CLN, Share Reorganisation and VST Update
29th Sep 20237:00 amRNSBoard Change
29th Sep 20237:00 amRNSProposed New Commercial Partnership
29th Sep 20237:00 amRNSInterim Results
30th Aug 20237:00 amRNSVenatus Advertising Sales Partnership
23rd Aug 20234:47 pmRNSTR-1: Notification of Major Holdings
21st Jul 202311:23 amRNS2023 Annual General Meeting Results
18th Jul 202311:46 amRNSGeneral Meeting Requisition Request withdrawn
18th Jul 20237:00 amRNSBoard Changes
13th Jul 20231:32 pmRNSVirtual stadium partnership with first NFL team
11th Jul 20237:00 amRNSRequisitioned General Meeting
5th Jul 20237:00 amRNSRequest to requisition a General Meeting
21st Jun 20237:00 amRNSAnnual Report & Accounts and Notice of AGM
20th Jun 20238:18 amRNSFinal Results and Annual Report - replacement
20th Jun 20237:00 amRNSAnnual Report & Accounts and Notice of AGM
1st Mar 20235:28 pmRNSComment on Azerion Statement
15th Feb 20237:00 amRNSBidstack appoints Thomas Bullen as CFO
13th Feb 20232:05 pmRNSSecond Price Monitoring Extn
13th Feb 20232:00 pmRNSPrice Monitoring Extension
13th Feb 20237:00 amRNSTrading and Operational Update
18th Jan 202311:22 amRNSChange of Registered Office
3rd Jan 202311:05 amRNSSecond Price Monitoring Extn
3rd Jan 202311:00 amRNSPrice Monitoring Extension
3rd Jan 20237:00 amRNSAzerion Update
29th Dec 20227:00 amRNSBoard Changes
9th Dec 202211:04 amRNSGrant of LTIP Options
8th Dec 20227:00 amRNSExercise of Options, Issue of Equity & TVR
6th Dec 202211:03 amRNSTR-1: Notification of major holdings
5th Dec 20227:00 amRNSBidstack adds 2 titles with a AAA game publisher
1st Nov 20223:39 pmRNSTR-1: Notification of major holdings
31st Oct 20223:35 pmRNSTotal Voting Rights
31st Oct 20223:21 pmRNSTR-1: Notification of major holdings
31st Oct 20222:16 pmRNSTR-1: Notification of major holdings
31st Oct 202211:54 amRNSTR-1: Notification of major holdings
28th Oct 20224:16 pmRNSTR-1: Notification of Major Holdings
28th Oct 20227:00 amRNSUpdate re Press Commentary
26th Oct 20223:45 pmRNSAdmission of Ordinary Shares and TVR
26th Oct 20227:00 amRNSStrategy Update
25th Oct 202212:08 pmRNSResults of General Meeting
13th Oct 20227:00 amRNSBidstack appoints Camila Franklin as COO
6th Oct 20226:28 pmRNSResults of REX Retail Offer
6th Oct 20228:06 amRNSResults of Placing and Subscription
5th Oct 20224:36 pmRNSREX Retail Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.